BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17599930)

  • 1. Non-parametric quantification of protein lysate arrays.
    Hu J; He X; Baggerly KA; Coombes KR; Hennessy BT; Mills GB
    Bioinformatics; 2007 Aug; 23(15):1986-94. PubMed ID: 17599930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable slope normalization of reverse phase protein arrays.
    Neeley ES; Kornblau SM; Coombes KR; Baggerly KA
    Bioinformatics; 2009 Jun; 25(11):1384-9. PubMed ID: 19336447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein "fingerprinting" in complex mixtures with peptoid microarrays.
    Reddy MM; Kodadek T
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12672-7. PubMed ID: 16123137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a robust classifier for quality control of reverse-phase protein arrays.
    Ju Z; Liu W; Roebuck PL; Siwak DR; Zhang N; Lu Y; Davies MA; Akbani R; Weinstein JN; Mills GB; Coombes KR
    Bioinformatics; 2015 Mar; 31(6):912-8. PubMed ID: 25380958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer.
    Gonzalez-Angulo AM; Hennessy BT; Meric-Bernstam F; Sahin A; Liu W; Ju Z; Carey MS; Myhre S; Speers C; Deng L; Broaddus R; Lluch A; Aparicio S; Brown P; Pusztai L; Symmans WF; Alsner J; Overgaard J; Borresen-Dale AL; Hortobagyi GN; Coombes KR; Mills GB
    Clin Proteomics; 2011 Jul; 8(1):11. PubMed ID: 21906370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.
    Mermel CH; Schumacher SE; Hill B; Meyerson ML; Beroukhim R; Getz G
    Genome Biol; 2011; 12(4):R41. PubMed ID: 21527027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global proteomic identifies multiple cancer-related signaling pathways altered by a gut pathobiont associated with colorectal cancer.
    Pasquereau-Kotula E; Nigro G; Dingli F; Loew D; Poullet P; Xu Y; Kopetz S; Davis J; Peduto L; Robbe-Masselot C; Sansonetti P; Trieu-Cuot P; Dramsi S
    Sci Rep; 2023 Sep; 13(1):14960. PubMed ID: 37696912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial mitochondrial reactive oxygen species induction by lung epithelial immunometabolic modulation.
    Wang Y; Kulkarni VV; Pantaleón García J; Leiva-Juárez MM; Goldblatt DL; Gulraiz F; Vila Ellis L; Chen J; Longmire MK; Donepudi SR; Lorenzi PL; Wang H; Wong LJ; Tuvim MJ; Evans SE
    PLoS Pathog; 2023 Sep; 19(9):e1011138. PubMed ID: 37695784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Profile Distinguishes New Subpopulations of Breast Cancer Patients with Different Survival Outcomes.
    Tobiasz J; Polanska J
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
    Hoff FW; Qiu Y; Brown BD; Gerbing RB; Leonti AR; Ries RE; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Jenkins GN; Horton TM; Kornblau SM
    Proteomics Clin Appl; 2023 Nov; 17(6):e2200109. PubMed ID: 37287368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
    Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
    J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.
    Tang X; Thompson KJ; Kalari KR; Sinnwell JP; Suman VJ; Vedell PT; McLaughlin SA; Northfelt DW; Aspitia AM; Gray RJ; Carter JM; Weinshilboum R; Wang L; Boughey JC; Goetz MP
    Breast Cancer Res; 2023 May; 25(1):57. PubMed ID: 37226243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
    Meraz IM; Majidi M; Fang B; Meng F; Gao L; Shao R; Song R; Li F; Lissanu Y; Chen H; Ha MJ; Wang Q; Wang J; Shpall E; Jung SY; Haderk F; Gui P; Riess JW; Olivas V; Bivona TG; Roth JA
    Commun Biol; 2023 May; 6(1):509. PubMed ID: 37169941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
    Hubner SE; de Camargo Magalhães ES; Hoff FW; Brown BD; Qiu Y; Horton TM; Kornblau SM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial mitochondrial reactive oxygen species induction by lung epithelial metabolic reprogramming.
    Wang Y; Kulkarni VV; Pantaleón García J; Leiva-Juárez MM; Goldblatt DL; Gulraiz F; Chen J; Donepudi SR; Lorenzi PL; Wang H; Wong LJ; Tuvim MJ; Evans SE
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance.
    Ng ASN; Zhang S; Mak VCY; Zhou Y; Yuen Y; Sharma R; Lu Y; Zhuang G; Zhao W; Pang HH; Cheung LWT
    Cell Rep; 2022 Dec; 41(11):111821. PubMed ID: 36516775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.
    Shehwana H; Kumar SV; Melott JM; Rohrdanz MA; Wakefield C; Ju Z; Siwak DR; Lu Y; Broom BM; Weinstein JN; Mills GB; Akbani R
    Bioinformatics; 2022 Nov; 38(22):5131-5133. PubMed ID: 36205581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Sambandam V; Fernandez AM; Zhao H; Mazumdar T; Shen L; Wang Q; Ahmed KM; Ghosh S; Frederick MJ; Wang J; Johnson FM
    Cancer Res; 2022 Dec; 82(23):4444-4456. PubMed ID: 36169922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular heterogeneity of the precancerous breast affects drug efficacy.
    Bhardwaj A; Rojo RD; Ju Z; Koh A; Tachibana K; Wang J; Bedrosian I
    Sci Rep; 2022 Jul; 12(1):12590. PubMed ID: 35869155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-modal molecular programs regulate melanoma cell state.
    Andrews MC; Oba J; Wu CJ; Zhu H; Karpinets T; Creasy CA; Forget MA; Yu X; Song X; Mao X; Robertson AG; Romano G; Li P; Burton EM; Lu Y; Sloane RS; Wani KM; Rai K; Lazar AJ; Haydu LE; Bustos MA; Shen J; Chen Y; Morgan MB; Wargo JA; Kwong LN; Haymaker CL; Grimm EA; Hwu P; Hoon DSB; Zhang J; Gershenwald JE; Davies MA; Futreal PA; Bernatchez C; Woodman SE
    Nat Commun; 2022 Jul; 13(1):4000. PubMed ID: 35810190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.